Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MINIMAL RESIDUAL DISEASE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1132 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lacroix, J; Doeberitz, MV
      Technical aspects of minimal residual disease detection in carcinoma patients

      SEMINARS IN SURGICAL ONCOLOGY
    2. Hosch, SB; Braun, S; Pantel, K
      Characterization of disseminated tumor cells

      SEMINARS IN SURGICAL ONCOLOGY
    3. Weber, T; Klar, E
      Minimal residual disease in thyroid carcinoma

      SEMINARS IN SURGICAL ONCOLOGY
    4. Ghossein, RA; Bhattacharya, S
      Molecular detection and characterization of circulating tumor cells and micrometastases in prostatic, urothelial, and renal cell carcinomas

      SEMINARS IN SURGICAL ONCOLOGY
    5. Max, N; Keilholz, U
      Minimal residual disease in melanoma

      SEMINARS IN SURGICAL ONCOLOGY
    6. Slack, JL; Bi, WL; Livak, KJ; Beaubier, N; Yu, M; Clark, M; Kim, SH; Gallagher, RE; Willman, CL
      Pre-clinical validation of a novel, highly sensitive assay to detect PML-RAR alpha mRNA using real-time reverse-transcription polymerase chain reaction

      JOURNAL OF MOLECULAR DIAGNOSTICS
    7. Meijerink, J; Mandigers, C; van de Locht, L; Tonnissen, E; Goodsaid, F; Raemaekers, J
      A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR

      JOURNAL OF MOLECULAR DIAGNOSTICS
    8. Morecki, S; Yacovlev, E; Gelfand, Y; Uzi, I; Slavin, S
      Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma

      JOURNAL OF IMMUNOTHERAPY
    9. Grimwade, D
      The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    10. Kearney, L
      Molecular cytogenetics

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    11. Swirsky, DM; Richards, SJ
      Laboratory diagnosis of acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    12. Burnett, AK
      Treatment of acute myeloid leukaemia in younger patients

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    13. Torchilin, VP; Iakoubov, LZ; Estrov, Z
      Antinuclear autoantibodies as potential antineoplastic agents

      TRENDS IN IMMUNOLOGY
    14. Braun, S; Harbeck, N
      Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patients

      BREAST CANCER RESEARCH
    15. Pachmann, K; Heiss, P; Demel, U; Tilz, G
      Detection and quantification of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC (R))

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    16. Matsumura, M; Ijichi, M; Shiratori, Y; Togo, G; Hikiba, Y; Inoued, K; Kohara, M; Omata, M
      Simple quantitative assay of alpha-fetoprotein mRNA in liver tissue using the real-time detection polymerase chain reaction assay its application forclinical use

      HEPATOLOGY RESEARCH
    17. Snider, JV; Wechser, MA; Lossos, IS
      Human disease characterization: real-time quantitative PCR analysis of gene expression

      DRUG DISCOVERY TODAY
    18. Luo, V; Lessin, SR; Wilson, RB; Rennert, H; Tozer, C; Benoit, B; Leonard, DGB
      Detection of clonal T-cell receptor gamma gene rearrangements using fluorescent-based PCR and automated high-resolution capillary electrophoresis

      MOLECULAR DIAGNOSIS
    19. Bartolo, C; Viswanatha, DS
      Molecular methods for minimal residual disease detection in hematolymphoiddiseases: Principles and applications

      JOURNAL OF CLINICAL LIGAND ASSAY
    20. Weissman, IL; Anderson, DJ; Gage, F
      Stem and progenitor cells: Origins, phenotypes, lineage commitments, and transdifferentiations

      ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY
    21. Cheung, IY; Cheung, NKV
      Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR

      CLINICAL CANCER RESEARCH
    22. Li, GR; Passebosc-Faure, K; Lambert, C; Gentil-Perret, A; Blanc, F; Oosterwijk, E; Mosnier, JF; Genin, C; Tostain, J
      The expression of G250/MN/CA9 antigen by flow cytometry: Its possible implication for detection of micrometastatic renal cancer cells

      CLINICAL CANCER RESEARCH
    23. Pui, CH
      Risk assessment in acute lymphoblastic leukemia: Beyond leukemia cell characteristics

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    24. Fukuda, M; Miyajima, Y; Miyashita, Y; Horibe, K
      Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: A pilot study

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    25. Conte, PF; Gadducci, A; Cianci, C
      Second-line treatment and consolidation therapies in advanced ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    26. Wang, YL; Bagg, A; Pear, W; Nowell, PC; Hess, JL
      Chronic myelogenous leukemia: Laboratory diagnosis and monitoring

      GENES CHROMOSOMES & CANCER
    27. Krauter, J; Hoellge, W; Wattjes, MP; Nagel, S; Heidenreich, O; Bunjes, D; Ganser, A; Heil, G
      Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR

      GENES CHROMOSOMES & CANCER
    28. Gunzer, M; Janich, S; Varga, G; Grabbe, S
      Dendritic cells and tumor immunity

      SEMINARS IN IMMUNOLOGY
    29. Laczika, K; Mitterbauer, G; Mitterbauer, M; Knobl, P; Schwarzinger, I; Greinix, HT; Rabitsch, W; Fonatsch, C; Mannhalter, C; Lechner, K; Jaeger, U
      Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBF beta/MYH11 RT-PCR: Implications for a monitoring schedule and for treatment decisions

      LEUKEMIA & LYMPHOMA
    30. Kitzis, A; Brizard, F; Dascalescu, C; Chomel, JC; Guilhot, F; Brizard, A
      Persistence of transcriptionally silent BCR-ABL rearrangements in chronic myeloid leukemia patients in sustained complete cytogenetic remission

      LEUKEMIA & LYMPHOMA
    31. Vey, N; Balatzentko, G; LaFage, M; Sainty, D; Bouabdallah, R; Chabannon, C; Blaise, D; Gastaut, JA; Gabert, J
      Survey of early disapearance of BCR/ABL fusion transcript after allogeneicor autologous stem cell transplantation for chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    32. Barragan, E; Bolufer, P; Moreno, I; Martin, G; Nomdedeu, J; Brunet, S; Fernandez, P; Rivas, C; Sanz, MA
      Quantitative detection of AML1-ETO rearrangement by real-time RT-PCR usingfluorescently labeled probes

      LEUKEMIA & LYMPHOMA
    33. Yasukawa, M
      Immunotherapy for leukemia targeting the Wilms' tumor gene

      LEUKEMIA & LYMPHOMA
    34. Uckun, FM; Pallisgaard, N; Hokland, P; Navara, C; Narla, R; Gaynon, PS; Sather, H; Heerema, N
      Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia

      LEUKEMIA & LYMPHOMA
    35. Sakatani, T; Shimazaki, C; Hirai, H; Okano, A; Hatsuse, M; Okamoto, A; Takahashi, R; Ashihara, E; Inaba, T; Yokota, H; Nakahara, K; Hirai, H; Nakagawa, M
      Early relapse after high-dose chemotherapy rescued by tumor-free autologous peripheral blood stem cells in acute lymphoblastic leukemia: Importance of monitoring for WT1-mRNA quantitatively

      LEUKEMIA & LYMPHOMA
    36. Narla, RK; Navara, C; Sarquis, M; Uckun, FM
      Chemosensitivity of TEL-AML1 fusion transcript positive acute lymphoblastic leukemia cells

      LEUKEMIA & LYMPHOMA
    37. Buckstein, RJ; Rimrie, K; Pennell, N; Spaner, D; Hewitt, K; Berinstein, NL
      Prolonged molecular and clinical remission after treatment of a patient with follicular lymphoma with rituximab

      LEUKEMIA & LYMPHOMA
    38. Ladetto, M; Sametti, S; Astolfi, M; Corradini, P; Ricca, I; Drandi, D; Pileri, A; Tarella, C
      Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autografting

      LEUKEMIA & LYMPHOMA
    39. Verma, A; Stock, W
      Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach

      CURRENT OPINION IN ONCOLOGY
    40. Slavin, S; Nagler, A; Shapira, M; Panigrahi, S; Samuel, S; Or, A
      Non-myeloablative allogeneic stem cell transplantation focusing on immunotherapy of life-threatening malignant and non-malignant diseases

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    41. Jurcic, JG
      Antibody therapy for residual disease in acute myelogenous leukemia

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    42. Gebhart, E; Rosler, W; Gramatzki, M; Trautmann, U
      FISH monitoring of 100 courses of human leukemias: The cytogenetic viewpoint

      INTERNATIONAL JOURNAL OF ONCOLOGY
    43. Zelent, A; Guidez, F; Melnick, A; Waxman, S; Licht, JD
      Translocations of the RAR alpha gene in acute promyelocytic leukemia

      ONCOGENE
    44. Licht, JD
      AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML

      ONCOGENE
    45. Sugiyama, H
      Wilms' tumor gene WT1: Its oncogenic function and clinical application

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    46. Chen, ZX
      The possible role and application of WT1 in human leukemia

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    47. Kiyoi, H; Naoe, T
      Immunoglobulin variable region structure and B-cell malignancies

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    48. de Haas, V; van der Schoot, CE; van den Berg, H
      Risk assessment in ALL in children: A focus on PCR-based techniques for MRD detection

      ANNALS OF ONCOLOGY
    49. Machover, D; Delmas-Marsalet, B; Misra, SC; Gumus, Y; Goldschmidt, E; Schilf, A; Frenoy, N; Emile, JF; Debuire, B; Guettier, C; Farrokhi, P; Boulefdaoui, B; Norol, F; Parquet, N; Ulusakarya, A; Jasmin, C
      Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma

      ANNALS OF ONCOLOGY
    50. Bendandi, M; Tonelli, R; Maffei, R; Botti, S; Turi, C; Sartini, R; Inoges, S; Calvillo, MR; Zinzani, PL; Pession, A; Pileri, SA; Paolucci, G
      Identification of the B-cell tumor-specific molecular fingerprint using non-radiolabelled PCR consensus primers

      ANNALS OF ONCOLOGY
    51. Zittermann, SI; Achino, BI; Agriello, EE; Halperin, N; Ramhorst, RE; Fainboim, L
      Modulation of CD44 in acute lymphoblastic leukemia identifies functional and phenotypic differences of human B cell precursors

      EUROPEAN JOURNAL OF HAEMATOLOGY
    52. Lal, A; Kwan, E; Haber, M; Norris, MD; Marshall, GM
      Detection of minimal residual disease in peripheral blood prior to clinical relapse of childhood acute lymphoblastic leukaemia using PCR

      MOLECULAR AND CELLULAR PROBES
    53. Radich, JP
      Philadelphia chromosome-positive acute lymphocytic leukemia

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    54. Martin, TG; Linker, CA
      Autologous stem cell transplantation for acute lymphocytic leukemia in adults

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    55. Garcia-Manero, G; Thomas, DA
      Salvage therapy for refractory or relapsed acute lymphocytic leukemia

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    56. Szczepanksi, T; Willemse, MJ; van Wering, ER; van Weerden, JF; Kamps, WA; van Dongen, JJM
      Precursor-B-ALL with D-H-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14

      LEUKEMIA
    57. Lucio, P; Gaipa, G; van Lochem, EG; van Wering, ER; Porwit-MacDonald, A; Faria, T; Bjorklund, E; Biondi, A; van den Beemd, MWM; Baars, E; Vidriales, B; Parreira, A; van Dongen, JJM; San Miguel, JF; Orfao, A
      BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

      LEUKEMIA
    58. Andersson, A; Hoglund, M; Johansson, B; Lassen, C; Billstrom, R; Garwicz, S; Nilsson, PG; Mitelman, F; Fioretos, T
      Paired multiplex reverse-transcriptase polymerase chain reaction (PMRT-PCR) analysis as a rapid and accurate diagnostic tool for the detection of MLLfusion genes in hematologic malignancies

      LEUKEMIA
    59. Tobal, K; Moore, H; Macheta, M; Yin, JAL
      Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RAR alpha transcripts with a sensitive competitive RT-PCR method

      LEUKEMIA
    60. Marcucci, G; Caligiuri, MA; Dohner, H; Archer, KJ; Schlenk, RF; Dohner, K; Maghraby, EA; Bloomfield, CD
      Quantification of CBF beta/MYH11 fusion transcript by Real Time RT-PCR in patients with INV(16) acute myeloid leukemia

      LEUKEMIA
    61. Moravcova, J; Nadvornikova, S; Sieglova, Z; Formankova, R; Krskova, L; Dvorakova, R; Brdicka, R
      Do transcriptionally silent BCR-ABL cells persist in CML patients in molecular remission after stem cell transplantation?

      LEUKEMIA
    62. Pui, CH; Sailan, S; Relling, MV; Masera, G; Evans, WE
      International childhood Acute Lymphoblastic Leukemia workshop: Sausalito, CA, 30 November-1 December 2000

      LEUKEMIA
    63. Malec, M; Bjorklund, E; Soderhall, S; Mazur, J; Sjogren, AM; Pisa, P; Bjorkholm, M; Porwit-MacDonald, A
      Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL

      LEUKEMIA
    64. Tabernero, MD; Bortoluci, AM; Alaejos, I; Lopez-Berges, MC; Rasillo, A; Garcia-Sanz, R; Garcia, M; Sayagues, JM; Gonzalez, M; Mateo, G; San Miguel, JF; Orfao, A
      Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression

      LEUKEMIA
    65. Esteve, J; Villamor, N; Colomer, D; Cervantes, F; Campo, E; Carreras, E; Montserrat, E
      Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status

      LEUKEMIA
    66. Ambros, PF; Mehes, G; Hattinger, C; Ambros, IM; Luegmayr, A; Ladenstein, R; Gadner, H
      Unequivocal identification of disseminated tumor cells in the bone marrow by combining immunological and genetic approaches - functional and prognostic information

      LEUKEMIA
    67. zur Stadt, U; Harms, DO; Schluter, S; Schrappe, M; Goebel, U; Spaar, H; Janka, G; Kabisch, H
      MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen

      LEUKEMIA
    68. Thiede, C; Bornhauser, M; Oelschlagel, U; Brendel, C; Leo, R; Daxberger, H; Mohr, B; Florek, M; Kroschinsky, F; Geissler, G; Naumann, R; Ritter, M; Prange-Krex, G; Lion, T; Neubauer, A; Ehninger, G
      Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers

      LEUKEMIA
    69. Visani, G; Buonamici, S; Malagola, M; Isidori, A; Piccaluga, PP; Martinelli, G; Ottaviani, E; Grafone, T; Baccarani, M; Tura, S
      Pulsed ATRA as single therapy restores long-term remission in PML-RAR alpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study

      LEUKEMIA
    70. Brisco, MJ; Sykes, PJ; Hughes, E; Story, CJ; Rice, MS; Schwarer, AP; Morley, AA
      Molecular relapse can be detected in blood in a sensitive and timely fashion in B-lineage acute lymphoblastic leukemia

      LEUKEMIA
    71. Moreira, I; Papaioannou, M; Mortuza, FY; Gameiro, P; Palmisano, GL; Harrison, CJ; Prentice, HG; Mehta, AB; Hoffbrand, AV; Foroni, L
      Heterogeneity of VH-JH gene rearrangement patterns: an insight into the biology of B cell precursor ALL

      LEUKEMIA
    72. van der Pol, MA; Pater, JM; Feller, N; Westra, AH; van Stijn, A; Ossenkoppele, GJ; Broxterman, HJ; Schuurhuis, GJ
      Functional characterization of minimal residual disease for P-glycoproteinand multidrug resistance protein activity in acute myeloid leukemia

      LEUKEMIA
    73. Balduzzi, A; Gaipa, G; Bonanomi, S; Dassi, M; Perseghin, P; Buscemi, F; D'Aniello, E; Rovelli, A; Schiro, R; Longoni, D; Rambaldi, A; Uderzo, C; Biondi, A
      Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission: evidence for long-term clinical and molecular remissions

      LEUKEMIA
    74. de Haas, V; Verhagen, OJHM; von dem Borne, AEGK; Kroes, W; van den Berg, H; van der Schoot, CE
      Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy

      LEUKEMIA
    75. Mrozek, K; Prior, TW; Edwards, C; Marcucci, G; Carroll, AJ; Snyder, PJ; Koduru, PRK; Theil, KS; Pettenati, MJ; Archer, KJ; Caligiuri, MA; Vardiman, JW; Kolitz, JE; Larson, RA; Bloomfield, CD
      Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: A cancer and leukemia group B study

      JOURNAL OF CLINICAL ONCOLOGY
    76. Gerber, B; Krause, A; Muller, H; Richter, D; Reimer, T; Makovitzky, J; Herrnring, C; Jeschke, U; Kundt, G; Friese, K
      Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors

      JOURNAL OF CLINICAL ONCOLOGY
    77. Summers, KE; Goff, LJ; Wilson, AG; Gupta, RK; Lister, TA; Fitzgibbon, J
      Frequency of the Bcl-2/IgH rearrangement in normal individuals: Implications for the monitoring of disease in patients with follicular lymphoma

      JOURNAL OF CLINICAL ONCOLOGY
    78. Soignet, SL; Frankel, SR; Douer, D; Tallman, MS; Kantarjian, H; Calleja, E; Stone, RM; Kalaycio, M; Scheinberg, DA; Steinherz, P; Sievers, EL; Coutre, S; Dahlberg, S; Ellison, R; Warrell, RP
      United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    79. Merino, ME; Navid, F; Christensen, BL; Toretsky, JA; Helman, LJ; Cheung, NKV; Mackall, CL
      Immunomagnetic purging of Ewing's sarcoma from blood and bone marrow: Quantitation by real-time polymerase chain reaction

      JOURNAL OF CLINICAL ONCOLOGY
    80. Seeger, K; Stackelberg, AV; Taube, T; Buchwald, D; Korner, G; Suttorp, M; Dorffel, W; Tausch, W; Henze, G
      Relapse of TEL-AML1-Positive acute lymphoblastic leukemia in childhood: A matched-pair analysis

      JOURNAL OF CLINICAL ONCOLOGY
    81. Basso, G; Bernasconi, P; Chianese, R; Crovetti, G; Garbaccio, G; Iavarone, A; Pautasso, M; Santagostino, A; Stacchini, A
      Monoclonal antibody panels for acute leukemia and myelodysplastic syndromediagnosis - Results of a co-operative quality control group

      JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
    82. Basso, G; Lanza, F; Orfao, A; Moretti, S; Castoldi, G
      Clinical and biological significance of CD34 expression in acute leukemia

      JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
    83. Bahia, DMM; Yamamoto, M; Chauffaille, MDLF; Kimura, EYS; Bordin, JO; Filgueiras, MAC; Kerbauy, J
      Aberrant phenotypes in acute myeloid leukemia: a high frequency and clinical significance

      HAEMATOLOGICA

    84. The crucial role of immunophenotyping in hematology and oncology

      HAEMATOLOGICA
    85. Basso, G; Buldini, B; De Zen, L; Orfao, A
      New methodologic approaches for immunophenotyping acute leukemias

      HAEMATOLOGICA
    86. Miglino, M; Santini, G; Grasso, R; Pietrasanta, D; Clavio, M; Pierri, I; Canepa, L; Nati, S; Ballerini, F; Varaldo, R; Palmisano, G; Gobbi, M
      Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin's lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation

      HAEMATOLOGICA
    87. Munoz, L; Nomdedeu, JF; Brunet, S; Villamor, N; Tormo, M; Sierra, J
      CD56 expression could be associated with monocytic differentiation in acute myeloid leukemia with t(8;21)

      HAEMATOLOGICA
    88. Bolufer, P; Lo Coco, F; Grimwade, D; Barragan, E; Diverio, D; Cassinat, B; Chomienne, C; Gonzalez, M; Colomer, D; Gomez, MT; Marugan, I; Roman, J; Delgado, MD; Garcia-Marco, JA; Bornstein, R; Vizmanos, JL; Martinez, B; Jansen, J; Villegas, A; de Blas, JM; Cabello, P; Sanz, MA
      Variability in the levels of PML-RAR alpha fusion transcripts detected by laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocols

      HAEMATOLOGICA
    89. Gameiro, P; Vieira, S; Carrara, P; Silva, AL; Diamond, J; de Sousa, AB; Mehta, AB; Prentice, HG; Guimaraes, JE; Hoffbrand, AV; Foroni, L; Parreira, A
      The PML-RAR alpha transcript in long-term follow-up of acute promyelocyticleukemia patients

      HAEMATOLOGICA
    90. Germano, G; Songia, S; Biondi, A; Basso, G
      Rapid detection of clonality in patients with acute lymphoblastic leukemia

      HAEMATOLOGICA
    91. Amabile, M; Gannini, B; Testoni, N; Montefusco, V; Rosti, G; Zardini, C; Terragna, C; Buonamici, S; Ottaviani, E; Soverini, M; Fiacchini, M; Bassi, S; de Vivo, A; Trabacchi, E; Saglio, G; Pane, F; Baccarani, M; Tura, S; Martinelli, G
      Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia

      HAEMATOLOGICA
    92. Krampera, M; Perbellini, O; Maggioni, A; Scognamiglio, F; Todeschini, G; Pizzolo, G
      Flow-cytometric detection of minimal residual disease in adult acute lymphoblastic leukemia

      HAEMATOLOGICA
    93. Chillon, MC; Garcia-Sanz, R; Balanzategui, A; Ramos, F; Fernandez-Calvo, J; Rodriguez, MJ; Rodriguez-Salazar, MI; Corrales, A; Calmuntia, MJ; Orfao, A; Gonzalez, M; San Miguel, JF
      Molecular characterization of acute myeloblastic leukemia according to thenew WHO classification: a different distribution in Central-West Spain

      HAEMATOLOGICA
    94. Munoz, L; Nomdedeu, JF; Lopez, O; Carnicer, MJ; Bellido, M; Aventin, A; Brunet, S; Sierra, J
      Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies

      HAEMATOLOGICA
    95. Suarez, L; Vidriales, MB; Garcia-Larana, J; Lopez, A; Martinez, R; Martin-Reina, V; Tormo, M; Gonzalez-San Miguel, JD; Lavilla, E; Garcia-Boyero, R; Orfao, A; San Miguel, JF
      Multiparametric analysis of apoptotic and multidrug resistance phenotypes according to the blast cell maturation stage in elderly patients with acutemyeloid leukemia

      HAEMATOLOGICA
    96. Wakasugi, S; Ohta, K; Hasegawa, Y; Tatumi, N; Nakamura, H
      Defection of minimal residual disease in acute leukemia by Tc-99m MIBI femoral marrow imaging

      CLINICAL NUCLEAR MEDICINE
    97. Miyajima, K; Tamiya, S; Oda, Y; Adachi, T; Konomoto, T; Toyoshiba, H; Masuda, K; Tsuneyoshi, M
      Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma; real-time semi-quantitative reverse transcription-polymerase chain reaction

      CANCER LETTERS
    98. Jang, KA; Ahn, SJ; Choi, JH; Sung, KJ; Moon, KC; Koh, JK; Shim, YH
      Polymerase chain reaction (PCR) for human herpesvirus 8 and heteroduplex PCR for clonality assessment in angiolymphoid hyperplasia with eosinophilia and Kimura's disease

      JOURNAL OF CUTANEOUS PATHOLOGY
    99. Ladetto, M; Sametti, S; Donovan, JW; Ferrero, D; Astolfi, M; Mitterer, M; Ricca, I; Drandi, D; Corradini, P; Coser, P; Pileri, A; Gribben, JC; Tarella, C
      A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients

      EXPERIMENTAL HEMATOLOGY
    100. Lopez-Perez, R; Garcia-Sanz, R; Gonzalez, D; Balanzategui, A; Chillon, MC; Alaejos, I; Mateos, MV; Caballero, MD; Corral, M; Orfao, A; Gonzalez, M; San Miguel, JF
      Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiplemyeloma patients undergoing autologous peripheral blood stem cell transplantation

      BONE MARROW TRANSPLANTATION


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/10/20 alle ore 23:47:46